abstract |
The present invention relates to compounds that are rapidly dissociating dopamine 2 receptor antagonists, methods for producing these compounds, and pharmaceutical compositions comprising these compounds as active ingredients. The compound finds utility as a medicament for treating or preventing disorders of the central nervous system such as schizophrenia by exerting an antipsychotic effect without side effects of exercise. |